|
Per clinical trial (b)(6): on (b)(6) 2018, patient underwent bilateral augmentation mastopexy using a full vertical and horizontal t incision.2 pieces of galaform (galaflex 3dr) were used.No concomitant procedures were done.On (b)(6) 2019, right breast ptosis was reported.No action was taken.Patient may need skin excision on right breast.Review of medical affairs identified that the reported ae is likely related to the device and not serious.
|
|
Based on the information provided, no conclusions can be made.As reported, patient experienced the post-op complication of ptosis.Medical affairs has assessed the patient¿s postoperative course as being not serious and likely related to the study device.Review of the device history records confirmed the device was manufactured to specification.Note: this mdr report is related to a retrospective study conducted to proactively gather real-world evidence on the use and safety of the p4hb product family, including galaflex scaffold, galaflex 3d, and galaflex 3dr.All safety events from the study are adjudicated by the bd medical monitor for an independent assessment of severity and relatedness.In an abundance of caution, events for which relatedness cannot be ruled out are processed for mdr reporting.
|